The renal basic amino acid metabolism often differs in rodents, strict carnivore, and omnivore species. Given the pivotal role of L-arginine and L-ornithine in several metabolic pathways and the fact that the dog is closely related to humain being also an omnivore, we tested whether L-arginine metabolism and L-ornithine catabolism take place in the dog kidney. We examined the metabolic of L-arginine in dog cortical tubules to integrate local L-arginine metabolism into a general physiological and metabolic framework. To achieve these goals, we first ascertained the protein expression of relevant enzymes identified by Western blotting. Larginine catabolism was studied in suspensions of canine cortical proximal tubules, medullary thick ascending limbs, and papillary collecting ducts either incubated without exogenous Larginine being added (small endogenous quantities) or incubated with L-arginine being added in supraphysiological amounts (2 mmol/L with or without the presence of alternative metabolic substrates, 2 mmol/L L-glutamine, or lactate). The results revealed that dog kidneys consumed L-citrulline and released L-arginine and L-ornithine. Argininosuccinate synthetase and lyase, arginase II, and ornithine aminotransferase were detected in the renal cortex. Arginase II activity was found in a suspension of proximal tubules by measuring the amounts of urea and L-ornithine produced. A fraction of this L-ornithine was further partially metabolized through the intramitochondrial ornithine aminotransferase pathway, leading to changes in L-glutamate, glucose, L-alanine, and ammonia metabolism without L-proline accumulation. Medullary thick ascending limbs expressed a very low arginase activity whereas papillary collecting ducts did not. In conclusion, the dog kidney produces L-arginine. Part of this L-arginine is further catabolized by arginase II, suggesting that its physiological role was to produce L-ornithine for the body.
INTRODUCTION
The mammalian kidney expresses several enzymes involved in L-arginine anabolism and catabolism [1, 2] . The anabolic enzymes, namely, argininosuccinate synthetase (ASS, Enzyme Commission [EC] 6.3.4.5) and argininosuccinate lyase (ASL, EC 4.3.2.1), convert L-citrulline in the presence of L-aspartate and adenosine triphosphate (ATP) into L-arginine and fumarate within 2 steps (Fig. 1) . The catalytic, physical, and chemical properties of these enzymes as well as the enzymatic mechanisms have been analyzed in details in kidneys of different species including guinea pig and rat [3] . The contribution of the kidney in L-arginine synthesis was demonstrated by injecting L-[ureido- 14 C] L-citrulline to rats and by measuring the incorporation of labeled L-arginine into proteins [4] . In rats with intact kidneys, labeled proteins were detected in kidneys, muscle, liver, and brain, whereas, in rats with ligated renal pedicles, the incorporation of radioactivity into proteins was dramatically lowered [4] . In the same way, experiments performed on isolated perfused rat kidney showed a progressive reduction in perfusate L-[ureido- 14 C] L-citrulline associated with a progressive increase in L-
[guanidino- 14 C] L-arginine [5] . Furthermore, the expression of ASS and ASL genes based on the measurement of their transcripts, proteins, and enzyme activities has been reported during development of rat [6, 7] and mouse [8] kidneys as well as in adult rat [9] [10] [11] and mouse [12] kidneys. Physiological studies clearly demonstrated the renal synthesis of L-arginine by quantitating arterial and renal venous concentrations of L-citrulline and L-arginine. A net renal uptake of L-citrulline from the blood was closely matched by a release of L-arginine into the bloodstream of control rats [13] , rats with 5/6 nephrectomy [14] , mongrel dogs [15] , mice [16, 17] , and patients with chronic renal failure [18] . Within the mammalian kidney, ASS and ASL genes are constantly expressed in the cortex, and in a lesser extent, in the outer stripe of the outer medulla [19, 20] . More detailed studies revealed that these enzymes are localized in the proximal tubule (PT) and exhibit their highest activity in the proximal convoluted tubule (PCT) [8, [21] [22] [23] .
In the kidney, L-arginine catabolism is controlled by several enzymes including arginase type II (AII, EC 3.5.3.1), which hydrolyses L-arginine into urea and L-ornithine, and arginineglycine amidinotransferase (GAT, EC 2.1.4.1), which metabolizes L-arginine and L-glycine into guanidinoacetic acid and L-ornithine ( Fig. 1) . Although other enzymes metabolizing Larginine are expressed in the kidney, our attention is restricted to AII and GAT. The expression of an arginase gene in the kidney has been reported in rats [24] , rabbits [25] , mice [26, 27] , dogs [24, 28, 29] , humans [24, 27, 30] , and other species [24, 28, 31] (for review, see also [2, 31] ).
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In the dog kidney, the arginase activity is almost exclusively confined in the cortex compared with the other renal zones [28] . Within the dog cortex, arginase activity was twice higher in the superficial cortex than that in the deep cortex, whereas it was about 40-fold lower in the outer stripe of the outer medulla. In contrast, the red and white medullae were devoid of an arginase activity [28] . In dogs, the renal arginase isoform strongly differs from that of the liver [24] . In another report, it was concluded that the dog kidney is capable of de novo urea synthesis, suggesting the presence of an arginase activity [32] . Given the high cellular heterogeneity in the kidney, the enzyme exhibits a typical distribution pattern of expression along the nephron.
The expression of AII is constantly found in the cortical and outer medullary proximal straight tubules and in other nephron segments that varied from a species to another species [19, 23, [33] [34] [35] . The expression of GAT has been reported in kidneys of several rodents, dogs [36] , and humans [37] . Arginine-glycine amidinotransferase is found in the renal cortex and, in a lesser extent, in the outer stripe of the outer medulla. Detailed studies based on the use of immunological technology and microdissection of the nephron revealed that GAT is expressed only in the PT with the highest activity in the PCT [38, 39] .
In several species, given that the proximal tubular cells express the enzymes cited above, the steady-state tissular concentration of L-arginine may thus be finely regulated through changes in these opposite fluxes with consequences for the local metabolism of L-arginine and local urea production. In addition, the endogenous production of L-ornithine by AII and GAT as well as the cellular uptake of L-ornithine provide L-ornithine for ornithine decarboxylase (ODC, EC 4.1.1.17), the rate limiting enzyme of the polyamine pathway, and for ornithine aminotransferase (OAT, EC 2.6.1.13), the key enzyme involved in L-glutamate, L-glutamine, and L-proline synthesis.
An abundant literature supports that the renal metabolism of L-arginine and L-ornithine varied from one species to another species. For example, strict canivores such as cats are unable to produce sufficient amounts of L-citrulline to support their metabolic needs in L-arginine [21] .
In contrast, dogs are not strict carnivores and can eat less meat than cats. As omnivores, dog metabolism does not strongly differ from that of humans and might constitute an excellent experimental model when human kidneys are not available. At present, L-arginine metabolism is poorly studied in dog kidneys. This statement is supported by the lack of data concerning the renal expression of ASS and ASL genes and the precise identification of the segments of the dog nephron that are involved in L-arginine anabolism and catabolism as well as L-ornithine metabolism. In addition, the metabolic consequences of the expression of ASS, ASL, AII, and GAT on the other metabolic pathways have never been examined in the kidney. 
Amino acid determination in arterial and renal venous blood
Blood was collected in the renal vein of the left kidney and the abdominal aorta of 5 beagle dogs with a 23-gauge needle (Terumo, Neolus, Guyancourt, France) mounted on a 10 mL syringe (Terumo) heparinized (Heparin, Roche Diagnostics, Meylan, France) 1 day before the experiment and dried at room temperature. The tip of the needle was curved, pushed into the initial portion of the renal vein near the exit of the kidney, pointed toward the kidney, and pushed in the hilus to prevent blood backward surge from vena cava and spermatic vein. Four to five milliliters of blood were collected slowly and regularly at a maximum rate of 5 mL/min, transferred into lithium heparinized Vacutainer tubes, and maintained at 4°C. Blood was centrifuged at 11 700 g for 15 minutes at 4°C to collect the plasma. Two-hundred microliters of nonhemolyzed plasma were deproteinized by adding 20 µL of 30% sulfosalicylic acid, vortexed, put on ice for 60 minutes, and centrifuged at 11 700 g for 15 min at 4°C. The supernatant was collected and frozen at -80°C until amino acid analysis was carried out.
Plasma amino acids were determined in sulfosalicylic deproteinized samples by ion-exchange chromatography using a Jeol AminoTac amino acid analyser according to the manufacturer's hal-00306557, version 1 -28 Jul 2008 methodology. Before analysis, samples were half-diluted with a dilution buffer (Jeol) containing 2 amino acid standards: D-glucosaminic acid and 2-aminoethyl cysteine. Plasma from the National Quality Control for amino acid analysis was regularly used to check our method.
Preparation of tubule suspension for metabolic studies
The kidneys were removed, decapsulated, and placed in a modified ice-cold Krebs-Henseleit saline (KHS) composed of 112.7 mmol/L NaCl, 3.3 mmol/L KCl, 1.2 mmol/L KH 2 PO 4 , 1.2 mmol/L MgSO 4 , 0.5 mmol/L CaCl 2 , 50 mmol/L mannitol, 25 mmol/L NaHCO 3 (pH 7.4) at 37°C and osmolality at 350 mosm/kg. The superficial cortex, the inner stripe of the outer medulla, and the papilla were dissected with scissors. The tissues were then sliced using a Stadie-Riggs microtome to obtain slices of homogenous thickness. Slices were washed 3 times with ice-cold KHS to remove cell debris. Cortical tubules (> 85% PTs), MTALs, and papillary collecting ducts (PCDs) were prepared from relevant tissue by collagenase digestion as previously described [40] . After the digestion, the final suspension adjusted to 60 mg wet weight per milliliter was kept at 4°C in standard KHS fully gassed with 5% CO 2 + 95% O 2 until utilization [40] . Aliquots of the tubule suspensions were dried to obtain the tissue dry weight after subtraction of the weight due to salts and mannitol contained in KHS. 
Metabolic behaviour : substrates utilization and metabolites production
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At the end of the incubation, the content of the flasks was deproteinized with 0.4 mL 20% perchloric acid (PCA); and 4.3 mL of the supernatant were neutralized with 0.3 mL 40% KOH.
The following metabolites were measured enzymatically on the neutralized PCA extract [40, 41] : lactate, pyruvate, L-glutamine, L-glutamate, α-ketoglutarate, L-aspartate, L-alanine, NH 4 + , glucose, urea, L-arginine. Therefore, all intracellular and extracellular metabolites were measured together, allowing to calculate net extraction and production of metabolites irrespectively of intracellular concentration or compartmentation.
To know whether L-ornithine was produced by AII during the metabolic incubation, the supernatant was analyzed by 2-dimensional thin-layer chromotography as described by Bremer et al. [42] . Each plate (cellulose thin-layer plate 10 x 10 cm; Merck Frosst Canada, Kirkland, Quebec, Canada) was developed twice in solvant 1 (pyridine/dioxane/25% ammonia/water and external standards, using a Spectra-Physic integrator model SP4270.
Preparation of cytosolic and mitochondrial fractions by differential centifugation
The whole renal cortex of one dog and the outer stripe of the outer medulla of female rats were dissected at 4°C under a stereomicroscope. The dissected tissue was rapidly immersed in a buffer composed of 250 mmol/L sucrose, 10 mmol/L Tris-HCl, and 1 mmol/L Na 2 EDTA, (pH 7.6) homogenized using a motor-driven Potter-Elvehjem glass homogeneizer with a loose-fitting Teflon pestle (Bellco Glass, Vineland, NJ) and centrifuged at 600g for 10 minutes at 4°C to remove cell debris and the nuclear fraction. The supernatant (S1) was centrifuged at 12 000g for 15 minutes at 4°C to pellet the mitochondrial fraction. The supernatant (S2) was centrifuged at 128 000g for 60 minutes at 4°C (Optima TLA 100.2
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Ultracentrifuge, Beckman) to obtain proteins of the cytosolic fraction in the supernatant (S3).
To wash the mitochondria, the pellet was resuspended 3-times in the same buffer and centrifuged 12 000g for 15 min at 4°C. The cytosolic fraction was submitted to a speed-vac evaporation to concentrate the proteins. Protein concentrations were determined using the Bradford protein assay [45] . Cytosolic proteins and purified mitochondria were dissolved in glycerol, 0.1 mol/L dithioerythriol, and bromophenol blue [46] ), heated at 95°C for 5 minutes, and immediately dipped in a bath maintained at 4°C.
Western blot analyses
Two hundred-microgram samples of soluble proteins were subjected to 9% SDSpolyacrylamide gel electrophoresis (PAGE) containing 0.1% SDS applying 6 W per gel Immunoblots were incubated in 5% fat-free milk in 1x TBST with the primary polyclonal rabbit antibodies raised against ASS (dilution 1:1000) [47] , ASL (dilution 1:1000) [48] , OAT (CovalAb, Villeurbanne, France, dilution 1:1000) [49] , AII (CovalAb, dilution 1:500) [49] , aconitase (dilution 1:10000) [50] , and the monoclonal mouse antibody raised against the α-subunit F1-ATP synthase (dilution 1:5000) [49] . The antibodies were incubated separately for 60 minutes. Afterward, the immunoblot was rinced 3-times for 15 minutes in 1x TBST and incubated for 60 minutes with either a peroxidase-conjugated anti-rabbit immunoglobulin G (IgG) or a anti-mouse IgG secondary antibody (dilution 1:10000-1:20000) in 5% fat-free milk in 1x TBST. The immunoblot was washed 3-times for 15 minutes in 1x TBST and antibody binding was revealed using chemiluminescence (ECL) Western blotting kit. The ECL detection was performed using Kodak X-MAT films. Low-exposure film was scanned using 
Results and statistical analysis
The plasma levels of amino acids are expressed in micromoles per liter (mean ± SE, n = 5 dogs). Given that blood was sampled in the aorta (A) and the renal vein (V) of each dog, V-A difference was calculated for each amino acid; and where appropriate, statistical differences
were assessed using the non-parametric Wilcoxon test for paired data at the 95% level significance (StatView SE+Gr and StatView 5).
For the metabolic studies, PTs were incubated 30, 60, and 120 minutes. Given that plotting metabolic rates of PTs against incubation time revealed linearity up to 60 minutes for PTs, the data obtained at 120 minutes were discarded. To calculate the metabolic rate for each experimental condition and substrate, the data obtained at 30 minutes were multiplied by 2 and a mean value was calculated with the data abtained at 60 minutes. In contrast, for MTALs, we used the data obtained at 60 and 120 minutes to calculate a mean production per hour.
In Table 2 Tables 1 and 2 ) was found not significant. Only the main effects are reported because the interactions found could be explained by obvious mechanisms and could distract the reader from the main point of the article.
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3. RESULTS
Anabolism of L-arginine in the dog kidney
This experiment was conducted to know whether the dog kidneys synthesize L-arginine from L-citrulline as in other mammals except the carnivores ones [13] [14] [15] [16] [17] [18] 21] . This biochemical pathway requires the expression of ASS and ASL and the substrates L-citrulline and Laspartate. The concentration of plasma amino acids was measured in the renal vein (V) and aorta (A); and the renal balance (V-A) that reflects either a production and a release when the V-A difference is positive or an extraction and a consumption when the V-A difference is negative was calculated for each amino acid. Given that 24 L-amino acids were simultaneously detected by HPLC, we present their plasma concentrations in Table 1 and comment briefly on the data below.
The plasma concentration of L-citrulline was 16 ± 4 µmol/L higher in the aorta than that in the renal vein, indicating a significant uptake of L-citrulline by the kidney ( results suggest that the dog kidney might also synthesize L-taurine and express cysteine sulfinate decarboxylase. Concerning the low but significant release of other L-amino acids in the renal vein, it is conceivable that these L-amino acids originated from a significant catabolism of plasma proteins or peptides in the PTs [54] .
Expression of enzymes involved in L-arginine anabolism in the dog renal cortex
This experiment was performed to know whether the renal cortex of dogs expresses ASS and ASL proteins. Given that ASS and ASL are cytosolic enzymes, the cytosolic fraction of the dog cortex was purified by differential centrifugation and isolated mitochondria were used as negative control. Given that the antibodies used were not directed against the dog enzymes, identification of ASS and ASL was based on the homology of amino acid sequences between species. Dog mitochondria were characterized by aconitase (85 kDa) which is strictly located in the mitochondrial matrix (Fig. 3) . The purity of the preparation was shown by the lack of aconitase in the cytosolic fraction (Fig. 3) . The results clearly revealed that the expression of ASS and ASL proteins was restricted to the cytosolic fraction of the dog cortex ( NP_031520) and rat ASL (NCBI : NP_067588) proteins well recognized the dog proteins.
Catabolism of L-arginine in different nephron segments
Proximal tubules.
All the metabolic processes presented below were linear for at least 60 minutes (Fig. 4) , allowing the presentation of data as metabolic rates in Table 2 . In the absence of substrates, the
PTs used endogenous L-alanine, L-aspartate, and L-glutamate (≈12 µmol/[h g wet weight)]
and probably other endogenous L-amino acids such as L-arginine with regard to the low production of urea ( Table 2 , line 1). A small fraction of these L-amino acids were neoglucogenic because glucose accumulated (≈3 µmol/[h g wet weight)], whereas the main fraction was oxidized to support the production of energy. Indeed, the high production of NH 4 + indicated that L-amino acids were first desaminated before being catabolized and suggested that oxidation was the predominant metabolic pathway at play.
In the absence of exogenous L-arginine, the isolated tubules produced a very low amount of urea that was probably due to the intracellular storage of L-arginine. Indeed, the renal cortex of rats and rabbits contains higher levels of L-arginine than the blood and the other renal zones [55, 56] ; and PCT cells reabsorb the filtered amino acids including L-arginine [54, 57] . In
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contrast, incubation of suspension cortical tubules with L-arginine led to a stoechiometric and reciprocal disappearance of L-arginine (P < .001) and production of urea (P < .001) ( Table 2, In addition, a small peak corresponding to L-glutamate-γ-semialdehyde (RT, 11.51 minutes)
was also observed (data not shown). Because the exogenous L-arginine was metabolized into L-ornithine and urea, the present data strongly support that an arginase activity was expressed in the cortical tubules and more probably in the cortical PTs (85% PTs).
The partial catabolism of L-ornithine-derived from L-arginine was confirmed by the metabolic effects observed in presence of L-arginine as sole substrate : a net accumulation of L-glutamate (P < .004) with secondary modest inhibition of glutaminase activity (EC, 3.5.1.2), leading to a net reduction of ammonia production (P < .003) when no lactate could stimulate ammonia incorporation into L-glutamate (Table 2, Only the analysis of the main effects analyzed by ANOVA are presented on Table 2 . Indeed, the interactions found were fully expected: (1) 
Thick ascending limbs.
Because the production of urea and AII activity is extremely low in the rat, mouse, cat, and
Meriones shawii MTAL [34] , the suspension of dog MTAL was incubated for 60 and 120 minutes to enhance L-arginine catabolism and the amount of urea produced. In the absence of substrates, extremely low levels of urea were detected, whereas the net production of NH 4 + proved that endogenous L-amino acids were desaminated probably before being oxidized to sustain ATP production ( Table 3 , line 1). This process was decreased when adding lactate + pyruvate to the incubating medium (Table 3 , line 3). Incubation of MTAL with 2 mmol/L Larginine revealed that a very small amount of L-arginine was hydrolyzed with regard to the production of urea (Table 3 , line 2). This process was not modified by the presence of exogenous metabolic substrates (lactate + pyruvate). These results suggest that MTALs express a very low arginase activity.
Papillary collecting ducts.
In 2 experiments, the suspensions of dog PCDs were incubated for 120 minutes for the same reason as described for MTALs. Incubation of PCDs with L-arginine led to no significant hydrolysis of L-arginine and no production of urea either in the absence or in the presence of glucose as substrate (data not shown). These results suggest that PCDs probably do not express arginase gene.
Expression of enzymes catabolizing L-arginine and L-ornithine in the dog renal cortex
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Proteins of the renal cortex were analyzed by Western blot to prove that AII and OAT were expressed in dogs. The cytosolic and mitochondrial fraction of the dog renal cortex were separated by differential centrifugation. Mitochondria isolated from the outer stripe of the outer medulla of the female rat were used as a positive control because AII and OAT proteins are highly expressed in this renal zone [49] . As noted above and for the same reason, identification of the enzymes was based on the homology of amino acid sequences between species. As shown in Fig. 6 , rat and dog mitochondria were characterized by the α-subunit F1-ATP synthase (55 kDa), which is attached on the inner side of the inner membrane of the mitochondria. The lack of α-subunit F1-ATP synthase in the cytosolic fraction proved the purity of the preparation. As expected, AII and OAT proteins were highly expressed in the rat mitochondria. On this basis, our results reveal that the renal cortex of dogs expressed AII (38 kDa) and OAT (48 kDa identity and AS, 88.6% identity, respectively). Although the localization of ASS and ASL proteins were not performed in a suspension of dog PTs, it is known that the PTs are the most abundant tubules in the cortex [58, 63] and both enzymes are essentially expressed in the PCT of several species [20, 23] . Moreover, the PCT is the privileged site of L-citrulline reabsorption [64] . Altogether, this study proves that under normal physiological conditions, the dog kidney Although several enzymes control L-arginine catabolism in the kidney, our attention was restricted to AII. In PTs, the substrate L-arginine can be endogenously produced from Lcitrulline or can enter the cells at least by the apical membrane of the rat PT (reabsorption) [67] . To prevent the endogenous production of L-arginine, suspensions of tubules were incubated without L-citrulline. In the presence of exogenous L-arginine, PTs produced a high amount of urea that was accompanied by an equimolar diminution of L-arginine and a nearly equimolar accumulation of L-ornithine. Given that the renal arginase is localized in mitochondria [35, 68, 69] , our data support that L-arginine was also transported into mitochondria to be further metabolized. Our results showed that PTs expressed a high arginase activity compared with MTALs, whereas PCDs did not express this enzyme. The expression of an AII was clearly confirmed by analyzing on immunoblots mitochondrial proteins isolated from of the dog cortex (> 85% PTs). Our results are in a good agreement with the report of Rabinowitz et al [70] that depicted an arginase activity almost exclusively in the renal cortex.
Unfortunately, in our study, we omitted to test whether proximal straight tubules express an arginase activity. The distribution pattern of AII within the dog kidney strongly differs from those of rats and mice [33, 71] , but exhibits a similarity with those of rabbits, guinea pigs, cats,
and Meriones shawii, which expressed an arginase in their PCT [21, 33, 34] . The data obtained in dogs sustain the view that the renal distribution of AII is species specific. Given that the amino acid sequence of the dog AII (NCBI : XP_866822 and XP_537488) contains the IASSFGQTREGGHIVYD peptide sequence that shows 87.5% identity with the IASSFGQTREGGHIEC peptide sequence used to prepare our primary antibody and that a molecular weight of 38 kDa was found for the dog arginase in mitochondria, the dog AII might strongly resemble those of mice [35] and rats [49] .
Interestingly, in cells, several metabolic pathways are interconnected; and the presence or the absence of exogenous metabolites might modify the homeostasis of the end-product of these pathways. This is why we examined the metabolic consequences of L-arginine hydrolysis in a suspension of dog cortical PTs to integrate AII activity into a general physiological and metabolic framework. The metabolic behaviour of L-arginine was analyzed in detail to give an insight to (1) the metabolic fate of L-ornithine-derived from L-arginine hydrolysis and (2) the interaction between L-arginine catabolism and metabolites such as lactate and L-glutamine known to be also highly metabolized in this nephron segment (Fig. 1 ) [72, 73] . In cortical PTs, the rate of L-arginine hydrolysis apparently exceeded that of L-ornithine appearance because L-ornithine accumulation in the incubating medium corresponded to 76 to 85% of the amount of L-arginine hydrolyzed. In addition, we observed that the plasma concentration of Lornithine was higher in the renal vein than that in the aorta, indicating that the dog kidney released L-ornithine in the bloodstream. We calculated that the dog PT produced about 282 nmol of L-ornithine per millimeter per day. This value is dramatically higher than the values found for the PCT of cats [21] , guinea pigs [34] , rabbits [33] , and Meriones shawii [34] .
Consequently, we proposed that, in the dog kidney, the function of AII might be to supply circulating L-ornithine for the body. Release of L-ornithine from the kidney has been also observed in humans [18] .
The remaining 15% to 24% of L-ornithine derived from L-arginine can serve as precursor for putrescine, L-proline, and L-glutamate synthesis or can be oxidized to supply ATP for cellular functions. It is generally assumed that L-proline synthesis cannot occur in the kidney because the enzyme pyrroline-5-carboxylate reductase (EC 1.5. [72, 74, 75] . Interestingly, AII and OAT are also localized in the mitochondrial matrix [35, 49, 68, 69] and in the dog PT. To explain the concomitant decrease in L-glutamine utilization and L-glutamate accumulation, we hypothesized that a fraction of L-glutamate originated from the transamination of L-ornithine derived from L-arginine by OAT activity. In addition, the production of glutamate-γ-semialdehyde during the transamination step controlled by OAT might serve to produce a second molecule of L-glutamate (Fig. 1) . Given that Lglutamate is known to be the most important inhibitor of kidney-type glutaminase [72] , Lglutamate generated by OAT could negatively regulate phosphate-dependent glutaminase activity in the mitochondria.
Regarding the metabolic fate of L-glutamate produced by OAT, this amino acid serves either to synthesize L-glutamine or to regenerate α-ketoglutarate for another transamination step. The synthesis of L-glutamine is controlled by the enzyme glutamine synthetase (EC: 6.3.1.2) that is hal-00306557, version 1 -28 Jul 2008 expressed in the PT of the rat and rabbit kidneys [76] . In contrast to these species, the dog kidney does not express glutamine synthetase [77] . Consequently, the alternative route for Lglutamate is to undergo deamination by glutamate dehydrogenase to produce α-ketoglutarate that can be (1) completely oxidized in the Krebs cycle to supply energy for the cells, (2) used to transaminate a new molecule of L-ornithine, (3) used by aspartate transaminase (EC 2.6.1.1) and alanine aminotransferase (EC 2.6.1.2), or (4) recycled for gluconeogenesis (Fig. 1) .
Although the carbons of α-ketoglutarate can lead to the production of oxaloacetate and then to glucose in the gluconeogenic pathway, the carbons of L-ornithine derived from L-arginine did not contribute to glucose synthesis because the presence of L-arginine produced a modest inhibition of glucose synthesis in the presence of exogenous L-glutamine or lactate. This may be related to the increased level of L-glutamate modulating the intramitochondrial-limiting oxaloacetate concentration. The fact that L-alanine (with lactate) production was increased by L-arginine suggested that the increased in L-glutamate level was responsible for this finding, presumably through increased utilization of pyruvate towards amino acid synthesis. In the dog kidney, L-arginine is therefore not a major gluconeogenic L-amino acid. Fig. 1 Relationship between the metabolic pathways of L-arginine, L-ornithine, and other amino acids; the Krebs cycle; and the gluconeogenesis pathway in dog cortical PTs.
FIGURE LEGENDS
Enzymes are written in red, and the metabolites measured are written in green. In the Krebs cycle and gluconeogenesis, only the essential enzymatic steps are indicated.
The red cross indicates that GS is not expressed in the dog kidney. 
